AstraZeneca’s RSV Antibody May Need More Data Due To Impact Of Maternal Vaccines

 
• By Derrick Gingery
  
maternal vaccine
Children may not need a nirsevimab dose as early as thought if maternal RSV vaccines are introduced. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Post-Marketing Regulation & Studies

More from Product Reviews